Fluorocapsules allow in vivo monitoring of the mechanical stability of encapsulated islet cell transplants

Dian Arifin, Mangesh Kulkarni, Deepak Kadayakkara, Jeff W Bulte

Research output: Contribution to journalArticle

Abstract

Clinical trials that have used encapsulated islet cell therapy have been few and overall disappointing. This is due in part to the lack of suitable methods to monitor the integrity vs. rupture of transplanted microcapsules over time. Fluorocapsules were synthesized by embedding emulsions of perfluoro-15-crown-5-ether (PFC), a bioinert compound detectable by 19F MRI, into dual-alginate layer, Ba2+-gelled alginate microcapsules. Fluorocapsules were spherical with an apparent smooth surface and an average diameter of 428 ± 52 μm. After transplantation into mice, the 19F MRI signal of capsules remained stable for up to 90 days, corresponding to the total number of intact fluorocapsules. When single-alginate layer capsules were ruptured with alginate lyase, the 19F MRI signal dissipated within 4 days. For fluoroencapsulated luciferase-expressing mouse βTC6 insulinoma cells implanted into autoimmune NOD/ShiLtJ mice and subjected to alginate-lyase induced capsule rupture in vivo, the 19F MRI signal decreased sharply over time along with a decrease in bioluminescence imaging signal used as a measure of cell viability in vivo. These results indicate that maintenance of capsule integrity is essential for preserving transplanted cell survival, where a decrease in 19F MRI signal may serve as a predictive imaging surrogate biomarker for impending failure of encapsulated islet cell therapy.

Original languageEnglish (US)
Article number119410
JournalBiomaterials
Volume221
DOIs
StatePublished - Nov 1 2019

Fingerprint

Transplants
Mechanical stability
Alginate
Islets of Langerhans
Magnetic resonance imaging
Capsules
Monitoring
Cell- and Tissue-Based Therapy
Cells
Rupture
Cell Survival
Bioluminescence
Imaging techniques
Biomarkers
Inbred NOD Mouse
Insulinoma
Emulsions
Ethers
Luciferases
Transplantation

Keywords

  • Diabetes
  • Encapsulation
  • Islet cell transplantation
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Fluorocapsules allow in vivo monitoring of the mechanical stability of encapsulated islet cell transplants. / Arifin, Dian; Kulkarni, Mangesh; Kadayakkara, Deepak; Bulte, Jeff W.

In: Biomaterials, Vol. 221, 119410, 01.11.2019.

Research output: Contribution to journalArticle

@article{02e99ec8a710488c9cc50298fdc609b6,
title = "Fluorocapsules allow in vivo monitoring of the mechanical stability of encapsulated islet cell transplants",
abstract = "Clinical trials that have used encapsulated islet cell therapy have been few and overall disappointing. This is due in part to the lack of suitable methods to monitor the integrity vs. rupture of transplanted microcapsules over time. Fluorocapsules were synthesized by embedding emulsions of perfluoro-15-crown-5-ether (PFC), a bioinert compound detectable by 19F MRI, into dual-alginate layer, Ba2+-gelled alginate microcapsules. Fluorocapsules were spherical with an apparent smooth surface and an average diameter of 428 ± 52 μm. After transplantation into mice, the 19F MRI signal of capsules remained stable for up to 90 days, corresponding to the total number of intact fluorocapsules. When single-alginate layer capsules were ruptured with alginate lyase, the 19F MRI signal dissipated within 4 days. For fluoroencapsulated luciferase-expressing mouse βTC6 insulinoma cells implanted into autoimmune NOD/ShiLtJ mice and subjected to alginate-lyase induced capsule rupture in vivo, the 19F MRI signal decreased sharply over time along with a decrease in bioluminescence imaging signal used as a measure of cell viability in vivo. These results indicate that maintenance of capsule integrity is essential for preserving transplanted cell survival, where a decrease in 19F MRI signal may serve as a predictive imaging surrogate biomarker for impending failure of encapsulated islet cell therapy.",
keywords = "Diabetes, Encapsulation, Islet cell transplantation, Magnetic resonance imaging",
author = "Dian Arifin and Mangesh Kulkarni and Deepak Kadayakkara and Bulte, {Jeff W}",
year = "2019",
month = "11",
day = "1",
doi = "10.1016/j.biomaterials.2019.119410",
language = "English (US)",
volume = "221",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Fluorocapsules allow in vivo monitoring of the mechanical stability of encapsulated islet cell transplants

AU - Arifin, Dian

AU - Kulkarni, Mangesh

AU - Kadayakkara, Deepak

AU - Bulte, Jeff W

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Clinical trials that have used encapsulated islet cell therapy have been few and overall disappointing. This is due in part to the lack of suitable methods to monitor the integrity vs. rupture of transplanted microcapsules over time. Fluorocapsules were synthesized by embedding emulsions of perfluoro-15-crown-5-ether (PFC), a bioinert compound detectable by 19F MRI, into dual-alginate layer, Ba2+-gelled alginate microcapsules. Fluorocapsules were spherical with an apparent smooth surface and an average diameter of 428 ± 52 μm. After transplantation into mice, the 19F MRI signal of capsules remained stable for up to 90 days, corresponding to the total number of intact fluorocapsules. When single-alginate layer capsules were ruptured with alginate lyase, the 19F MRI signal dissipated within 4 days. For fluoroencapsulated luciferase-expressing mouse βTC6 insulinoma cells implanted into autoimmune NOD/ShiLtJ mice and subjected to alginate-lyase induced capsule rupture in vivo, the 19F MRI signal decreased sharply over time along with a decrease in bioluminescence imaging signal used as a measure of cell viability in vivo. These results indicate that maintenance of capsule integrity is essential for preserving transplanted cell survival, where a decrease in 19F MRI signal may serve as a predictive imaging surrogate biomarker for impending failure of encapsulated islet cell therapy.

AB - Clinical trials that have used encapsulated islet cell therapy have been few and overall disappointing. This is due in part to the lack of suitable methods to monitor the integrity vs. rupture of transplanted microcapsules over time. Fluorocapsules were synthesized by embedding emulsions of perfluoro-15-crown-5-ether (PFC), a bioinert compound detectable by 19F MRI, into dual-alginate layer, Ba2+-gelled alginate microcapsules. Fluorocapsules were spherical with an apparent smooth surface and an average diameter of 428 ± 52 μm. After transplantation into mice, the 19F MRI signal of capsules remained stable for up to 90 days, corresponding to the total number of intact fluorocapsules. When single-alginate layer capsules were ruptured with alginate lyase, the 19F MRI signal dissipated within 4 days. For fluoroencapsulated luciferase-expressing mouse βTC6 insulinoma cells implanted into autoimmune NOD/ShiLtJ mice and subjected to alginate-lyase induced capsule rupture in vivo, the 19F MRI signal decreased sharply over time along with a decrease in bioluminescence imaging signal used as a measure of cell viability in vivo. These results indicate that maintenance of capsule integrity is essential for preserving transplanted cell survival, where a decrease in 19F MRI signal may serve as a predictive imaging surrogate biomarker for impending failure of encapsulated islet cell therapy.

KW - Diabetes

KW - Encapsulation

KW - Islet cell transplantation

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=85070593323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070593323&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2019.119410

DO - 10.1016/j.biomaterials.2019.119410

M3 - Article

C2 - 31421313

AN - SCOPUS:85070593323

VL - 221

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

M1 - 119410

ER -